Cryoport Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Cryoport Inc Company

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.

Cryoport Inc Info



Ticker SymbolCYRX

Company nameCryoport Inc

IPO dateJul 24, 2015

CEOMr. Jerrell Wilson (Jerry) Shelton

Number of employees1090

Security typeOrdinary Share

Fiscal year-endJul 24

Address112 Westwood Place, Suite 350

CityBRENTWOOD

Stock exchangeNASDAQ Capital Market Consolidated

CountryUnited States of America

Postal code37027

Phone19492321900

Websitehttps://www.cryoport.com/

Ticker SymbolCYRX

IPO dateJul 24, 2015

CEOMr. Jerrell Wilson (Jerry) Shelton

Company Executives of Cryoport Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

1.00M

+2.56%

Mr. Daniel M. (Dan) Hancock

Independent Director

45.86K

+102.52%

Ms. Linda Baddour

Independent Director

44.90K

+107.03%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

38.43K

+186.15%

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Mr. Robert S. Stefanovich

Chief Financial Officer, Senior Vice President, Chief Administrative Officer

--

Mr. Ram M. Jagannath

Independent Director

--

Mr. Scott Eckstein

Investor Relations

--

Mr. Edward J. Zecchini

Senior Vice President, Chief Digital and Technology Officer

--

Name

Name/Position

Position

Shareholding

Change

Mr. Jerrell Wilson (Jerry) Shelton

Chairman of the Board, President, Chief Executive Officer

1.00M

+2.56%

Mr. Daniel M. (Dan) Hancock

Independent Director

45.86K

+102.52%

Ms. Linda Baddour

Independent Director

44.90K

+107.03%

Dr. Robert J. (Bob) Hariri, M.D., Ph.D.

Independent Director

38.43K

+186.15%

Mr. Mark Sawicki

Senior Vice President, Chief Scientific Officer

--

Dr. Ramkumar Mandalam, Ph.D.

Independent Director

--

Revenue Breakdown

Currency: USDUpdated: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

By BusinessUSD

Name

Revenue

Proportion

BioLogistics solutions

18.53M

45.15%

Life Science products

18.18M

44.29%

BioStorage/Bioservices

4.33M

10.56%

By RegionUSD

Name

Revenue

Proportion

Americas

32.20M

78.45%

Europe & Middle East & Africa (EMEA)

5.58M

13.60%

Asia Pacific

3.27M

7.96%

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

BioLogistics solutions

18.53M

45.15%

Life Science products

18.18M

44.29%

BioStorage/Bioservices

4.33M

10.56%

Shareholding Stats

Updated: Thu, May 15

Shareholders

Shareholder Types

Shareholders

Proportion

Cadian Capital Management LP

9.93%

Morgan Stanley & Co. LLC

9.08%

Brown Capital Management, LLC

7.59%

BlackRock Institutional Trust Company, N.A.

6.80%

The Vanguard Group, Inc.

5.57%

Other

61.03%

Shareholders

Proportion

Cadian Capital Management LP

9.93%

Morgan Stanley & Co. LLC

9.08%

Brown Capital Management, LLC

7.59%

BlackRock Institutional Trust Company, N.A.

6.80%

The Vanguard Group, Inc.

5.57%

Other

61.03%

Shareholder Types

Shareholders

Proportion

Investment Advisor

41.49%

Investment Advisor/Hedge Fund

24.43%

Hedge Fund

19.45%

Research Firm

10.44%

Individual Investor

4.01%

Pension Fund

2.44%

Private Equity

1.24%

Bank and Trust

0.68%

Sovereign Wealth Fund

0.43%

Institutional Shareholding



Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

394

50.37M

100.47%

-14.50M

2025Q1

409

50.98M

101.73%

-14.79M

2024Q4

407

51.87M

104.93%

-14.28M

2024Q3

422

52.00M

105.24%

-13.61M

2024Q2

423

53.55M

108.72%

-9.95M

2024Q1

437

55.31M

112.51%

-7.56M

2023Q4

468

54.03M

110.37%

-6.18M

2023Q3

482

49.41M

101.04%

-7.52M

2023Q2

492

49.81M

109.19%

-5.40M

2023Q1

500

48.02M

99.15%

-8.43M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Cadian Capital Management LP

4.98M

9.94%

+55.00K

+1.12%

Mar 31, 2025

Morgan Stanley & Co. LLC

4.61M

9.19%

-2.84K

-0.06%

Mar 31, 2025

Brown Capital Management, LLC

4.05M

8.09%

-405.16K

-9.09%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

3.25M

6.49%

+229.97K

+7.61%

Mar 31, 2025

The Vanguard Group, Inc.

2.75M

5.48%

+13.24K

+0.48%

Mar 31, 2025

Millennium Management LLC

3.36M

6.71%

-778.06K

-18.79%

Mar 31, 2025

Fred Alger Management, LLC

2.53M

5.05%

-34.58K

-1.35%

Mar 31, 2025

Natixis Investment Managers SA

1.70M

3.39%

-15.64K

-0.91%

Mar 31, 2025

Thematics Asset Management SAS

617.20K

1.23%

-131.80K

-17.60%

Jun 30, 2024

Geode Capital Management, L.L.C.

1.12M

2.23%

+21.35K

+1.95%

Mar 31, 2025

Related ETFs



Name

Proportion

No Data

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data